Celeste Richardson

2.1k total citations · 1 hit paper
16 papers, 1.6k citations indexed

About

Celeste Richardson is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Celeste Richardson has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Celeste Richardson's work include CAR-T cell therapy research (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cellular transport and secretion (3 papers). Celeste Richardson is often cited by papers focused on CAR-T cell therapy research (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cellular transport and secretion (3 papers). Celeste Richardson collaborates with scholars based in United States, Germany and United Kingdom. Celeste Richardson's co-authors include John Blenis, Diane C. Fingar, Andrew R. Tee, Lynn Cheatham, Kristina Jülich, Nava Segev, Xiaoju Max, Stefanie S. Schalm, Gregory Jedd and Bryan A. Ballif and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Celeste Richardson

15 papers receiving 1.6k citations

Hit Papers

mTOR Controls Cell Cycle Progression through Its Cell Gro... 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E
    2003 733 citations Diane C. Fingar, Celeste Richardson et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celeste Richardson United States 12 1.2k 296 223 146 142 16 1.6k
Jan Saras Sweden 13 1.1k 0.9× 403 1.4× 212 1.0× 119 0.8× 132 0.9× 16 1.6k
Michelle L. Matter United States 18 968 0.8× 411 1.4× 192 0.9× 161 1.1× 203 1.4× 43 1.5k
Giulia Ramazzotti Italy 27 1.2k 1.0× 349 1.2× 171 0.8× 116 0.8× 289 2.0× 67 1.6k
Natalia Mitin United States 20 1.0k 0.8× 363 1.2× 358 1.6× 189 1.3× 127 0.9× 31 1.5k
L. S. P. Davidson United Kingdom 24 1.1k 0.9× 166 0.6× 169 0.8× 155 1.1× 115 0.8× 50 1.6k
Pascal Gélébart Canada 25 1.1k 0.9× 349 1.2× 301 1.3× 316 2.2× 176 1.2× 46 1.7k
Yi Jin United States 21 1.2k 1.0× 162 0.5× 266 1.2× 140 1.0× 206 1.5× 40 1.8k
Laura Asnaghi United States 20 924 0.7× 218 0.7× 230 1.0× 142 1.0× 225 1.6× 38 1.4k
Nancy L. Johnson United States 13 1.4k 1.1× 330 1.1× 279 1.3× 217 1.5× 232 1.6× 13 1.8k
Stephanie Z. Xie United States 14 930 0.8× 393 1.3× 224 1.0× 242 1.7× 237 1.7× 22 1.6k

Countries citing papers authored by Celeste Richardson

Since Specialization
Citations

This map shows the geographic impact of Celeste Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celeste Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celeste Richardson more than expected).

Fields of papers citing papers by Celeste Richardson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celeste Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celeste Richardson. The network helps show where Celeste Richardson may publish in the future.

Co-authorship network of co-authors of Celeste Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Celeste Richardson. A scholar is included among the top collaborators of Celeste Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celeste Richardson. Celeste Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Richardson, Celeste, et al.. (2024). Use of systemic therapies for vulvar lichen sclerosus and vulvovaginal lichen planus: a survey study of dermatologists and gynecologists. International Journal of Women’s Dermatology. 10(2). e146–e146.
2.
Ingram, John R, Vincenzo Bettoli, Georgios Kokolakis, et al.. (2022). Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US. Journal of the European Academy of Dermatology and Venereology. 36(9). 1597–1605. 35 indexed citations
3.
Richardson, Celeste, Finola E. Moore, Luke Barron, et al.. (2022). Abstract 555: Allogeneic Natural Killer cells engineered to express HER2 CAR, Interleukin 15 and TGF beta dominant negative receptor effectively control HER2+ tumors. Cancer Research. 82(12_Supplement). 555–555. 1 indexed citations
4.
Choi, Eugene, Walker S. Lahr, Emily J. Pomeroy, et al.. (2021). Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies. Blood. 138(Supplement 1). 1691–1691. 20 indexed citations
5.
Kenderian, Saad S., Marco Ruella, Olga Shestova, et al.. (2017). Targeting CLEC12A with Chimeric Antigen Receptor T Cells Can Overcome the Chemotherapy Refractoriness of Leukemia Stem Cells. Biology of Blood and Marrow Transplantation. 23(3). S247–S248. 10 indexed citations
6.
Dong, Linda M., Saar Gill, Vijay Bhoj, et al.. (2016). 399. Evaluation of CD123 Targeting CART Cells in Non-Human Primates. Molecular Therapy. 24. S158–S158. 2 indexed citations
7.
Garfall, Alfred L., Eric Lancaster, Edward A. Stadtmauer, et al.. (2016). Posterior Reversible Encephalopathy Syndrome (PRES) after Infusion of Anti-Bcma CAR T Cells (CART-BCMA) for Multiple Myeloma: Successful Treatment with Cyclophosphamide. Blood. 128(22). 5702–5702. 36 indexed citations
8.
Kenderian, Saad S., Marco Ruella, Olga Shestova, et al.. (2016). Leukemia Stem Cells Are Characterized By CLEC12A Expression and Chemotherapy Refractoriness That Can be Overcome By Targeting with Chimeric Antigen Receptor T Cells. Blood. 128(22). 766–766. 11 indexed citations
9.
Max, Xiaoju, et al.. (2008). SKAR Links Pre-mRNA Splicing to mTOR/S6K1-Mediated Enhanced Translation Efficiency of Spliced mRNAs. Cell. 133(2). 303–313. 245 indexed citations
10.
Richardson, Celeste, Stefanie S. Schalm, & John Blenis. (2004). PI3-kinase and TOR: PIKTORing cell growth. Seminars in Cell and Developmental Biology. 15(2). 147–159. 111 indexed citations
11.
Richardson, Celeste, Mark Bröenstrup, Diane C. Fingar, et al.. (2004). SKAR Is a Specific Target of S6 Kinase 1 in Cell Growth Control. Current Biology. 14(17). 1540–1549. 155 indexed citations
12.
Fingar, Diane C., et al.. (2003). mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E. Molecular and Cellular Biology. 24(1). 200–216. 733 indexed citations breakdown →
13.
Martin, Kathleen A., et al.. (2001). Regulation of Ribosomal S6 Kinase 2 by Effectors of the Phosphoinositide 3-Kinase Pathway. Journal of Biological Chemistry. 276(11). 7884–7891. 53 indexed citations
14.
Richardson, Celeste, et al.. (1998). GTP Hydrolysis Is Not Important for Ypt1 GTPase Function in Vesicular Transport. Molecular and Cellular Biology. 18(2). 827–838. 41 indexed citations
15.
Jones, Sara, et al.. (1998). Identification of Regulators for Ypt1 GTPase Nucleotide Cycling. Molecular Biology of the Cell. 9(10). 2819–2837. 30 indexed citations
16.
Jedd, Gregory, et al.. (1995). The Ypt1 GTPase is essential for the first two steps of the yeast secretory pathway.. The Journal of Cell Biology. 131(3). 583–590. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Saras Breakdown of academic impact, for papers by Michelle L. Matter Breakdown of academic impact, for papers by Giulia Ramazzotti Breakdown of academic impact, for papers by Natalia Mitin Breakdown of academic impact, for papers by L. S. P. Davidson Breakdown of academic impact, for papers by Pascal Gélébart Breakdown of academic impact, for papers by Yi Jin Breakdown of academic impact, for papers by Laura Asnaghi Breakdown of academic impact, for papers by Nancy L. Johnson Breakdown of academic impact, for papers by Stephanie Z. Xie
Rankless by CCL
2026